In the healthy control group, a better first-phase insulin secretion response to glucose load could have been aimed at compensating their borderline insulin resistance (HOMA of 2.5), or alternatively, subjects with RPH had a blunted first-phase insulin response as a primary defect in glucose regulation. This evidence concerns the gene INS and Insulin resistance.